Abbott Laboratories
People also watch:ABBVBMYLLYJNJMRK
43.530.12 (0.29%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close43.41
Bid43.50 x 1000
Ask43.51 x 2600
52wk Range36.00 - 51.24
Day's Range43.36 - 43.58
Avg Vol (3m)11,651,476
As of 12:47 PM EDT. NYSE Real Time Price. Market open.
  • TheStreet.com21 minutes ago

    Top 10 Dividend Aristocrats to Buy at a Discount Now

    These 10 dividend aristocrat stocks offer an average high yield of 3% and have increased dividends for 46 consecutive years on average.

  • American City Business Journals22 hours ago

    Massachusetts class-action lawsuit filed over Alere's blood test

    Adding to a lengthy list of problems faced by Waltham-based diagnostics firm Alere as it aims to complete its merger with Abbott came one more late last week: A new class-action lawsuit over a home blood coagulation test that was recalled over concerns of ita accuracy. The lawsuit is similar to one filed in California last month, according to John Roddy, a partner in the Boston offices of Alabama-based law firm Bailey & Glasser LLP, which filed the latest class-action lawsuit against Alere on Friday in federal court in Boston. Both address problems with the INRatio home blood test sold by Alere (ALR), used by patients who take blood thinners to determine the optimum size of dose needed for treatment.